Nevro Obtains $48,000,000 Series C Funding Round

  • Feed Type
  • Date
    3/7/2013
  • Company Name
    Nevro
  • Mailing Address
    4040 Campbell Avenue Menlo Park, CA 94025
  • Company Description
    Nevro is a medical device company developing novel neuromodulation therapies for multiple indications. The company’s initial focus is the development of an implantable device for the treatment of chronic pain.
  • Website
    http://www.nevrocorp.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $48,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The funds will be used to sponsor the ongoing U.S. pivotal clinical study, invest in clinical evidence for new indications and support the company’s international and U.S. commercialization plans.
  • M&A Terms
  • Venture Investor
    Novo Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Covidien Ventures
  • Venture Investor
    Accuitive Medical Ventures
  • Venture Investor
    Bay City Capital
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    Mayo Medical Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    Three Arch Partners

By posting a comment, you agree to our terms and conditions.